Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection-Reference-Cited by-同舟云学术

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

Published:2021-05-17 Issue:7 Volume:27 Page:1205-1211
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Khoury David S.^ORCID,Cromer Deborah^ORCID,Reynaldi Arnold^ORCID,Schlub Timothy E.,Wheatley Adam K.^ORCID,Juno Jennifer A.^ORCID,Subbarao Kanta,Kent Stephen J.^ORCID,Triccas James A.^ORCID,Davenport Miles P.^ORCID

Funder

Department of Health | National Health and Medical Research Council

Department of Health, Australian Government

State Government of Victoria

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/s41591-021-01377-8.pdf

Reference61 articles.

1. Lumley, S. F. et al. Antibody status and incidence of SARS-CoV-2 infection in health care workers. N. Engl. J. Med. 384, 533–540 (2021).

2. Kim, J. H., Marks, F. & Clemens, J. D. Looking beyond COVID-19 vaccine phase 3 trials. Nat. Med. 27, 205–211 (2021).

3. Wheatley, A. K. et al. Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19. Nat. Commun. 12, 1162 (2021).

4. Gaebler, C. et al. Evolution of antibody immunity to SARS-CoV-2. Nature 591, 639–644 (2021).

5. Dan, J. M. et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science 371, eabf4063 (2021).

Cited by 3321 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Delivery of SARS-CoV-2 spike and membrane genes in a single Baculoviral vector enhance the immune breadth against SARS-CoV-2 variants of concern;Vaccine;2024-12

2. Should SARS-CoV-2 serological testing be used in the decision to deliver a COVID-19 vaccine booster? A pro-con assessment;Vaccine;2024-11

3. Relative vaccine effectiveness of ChAdOx1/AZD1222 vaccines as booster dose via intradermal injection with a one-fifth dose compared with the intramuscular injection in the prevention of SAR-CoV-2 infections in Phuket: A retrospective cohort study;International Journal of Infectious Diseases;2024-10

4. Delayed peak antibody titers after the second dose of SARS-CoV-2 vaccine in solid organ transplant recipients: Prospective cohort study;Vaccine;2024-10

5. Transdermal microneedles integrating biomimetic self-adjuvant particles for enhanced immunity;Nano Today;2024-10